Melbourne, Thursday 21 November to Monday 25 November
With major support from the Melbourne Academic Centre for Health (MACH) and co-sponsorship from Monash Partners and Australian Clinical Trials Alliance, ViCBiostat is conducting three days of workshops to assist policy makers, clinician researchers, early career researchers and biostatisticians understand the options and merits of various pragmatic randomised designs to evaluate the impact of health policy and practice change interventions.
Speakers include two international guest presenters Prof Karla Hemming (UK) and A/Prof Monica Taljaard (Canada) along with our local experts in the field Prof Andrew Forbes, Dr Jessica Kasza and A/Prof Joanne McKenzie.
Particular attention will be paid to the stepped wedge design, which couples rigorous scientific evaluation of the effect of an intervention with policy or practice implementation at scale.
Day 1 & 2 – November 21 & 22: Design, conduct, analysis and reporting of pragmatic stepped-wedge and related cluster randomised trial designs
Target audience: clinical & health services researchers, trialists and biostatisticians
Day 3 – November 25: The stepped-wedge and related cluster randomised trial designs: tools for evidence-based policy and practice (overview)
Target audience: clinicians and health policy makers as well as researcher
For further details on the workshop content: http://www.vicbiostat.org.au/workshop
Register here: https://www.trybooking.com/BFIDS
Venue: University of Melbourne, Lecture Theatre 2, Basement, 221 Bouverie St, Carlton
How do adaptive trial sizes work?
What is an adaptive clinical trial?
What is response adaptive randomisation?
Data Safety and Monitoring Boards (DSMB) for Adaptive Trials Webinar video
Data Safety and Monitoring Boards (DSMB) for Adaptive Trials Webinar slides
Bayesian adaptive randomised clinical trials flyer
Adaptive Design Clinical Trials
Hackathon of Novel Trial Designs part two
Hackathon of Novel Trial Designs part one
Studies Within A Trial SWATs webinar
Innovative Trial Design and Conduct Reference Group Objectives and Directions
Novel approaches to healthcare effectiveness research outside Australia